MMED financial statements and SEC filings
MMED annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2026-04-24 | $3.10B | -$190.00M | -$333.00M | 10-K |
| 2025-04-25 | $2.71B | -$146.00M | -$213.00M | 10-K |
| 2024-04-26 | $2.47B | -$69.00M | -$112.00M | 10-K |
MMED annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2026-04-24 | $4.63B | $1.02B | $3.61B | 10-Q |
| 2025-04-25 | $4.20B | $871.00M | $3.33B | 10-K |
MMED annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2026-04-24 | -$197.00M | -$223.00M | $716.00M | 10-K |
| 2025-04-25 | $140.00M | -$193.00M | $10.00M | 10-K |
| 2024-04-26 | $41.00M | -$148.00M | $112.00M | 10-K |